stock upgrade
TD Cowen Upgrades Shares of Pacific Biosciences to Outperform
A survey revealed that labs with multiple PacBio Sequel instruments plan to buy an average of three Revio sequencers each, TD Cowen Analyst Dan Brennan said.
Twist Bioscience Shares Upgraded to Outperform by Evercore ISI
Evercore cited the synthetic DNA maker's response to a recent report from a short seller that dragged down its shares toward the end of 2022.
Cowen Upgrades PerkinElmer Stock to Outperform
Analyst Max Masucci said the firm is expected to generate at least $3.21 billion in COVID-19-related revenues, while he lowered the stock price target to $164 per share.
Illumina Upgraded to Outperform by Evercore ISI
The stock upgrade comes right before an event where Illumina has said it will provide information on a new sequencing-by-synthesis chemistry.
Illumina, Belgium Genetic Centers Partner on WGS-Based Diagnostics; Evercore Upgrades Illumina Shares
The San Diego-based sequencing technology firm is also launching noninvasive prenatal genetic testing on the VeriSeq v2 platform in Thailand.